May 25 (Reuters) - Aroa Biosurgery Ltd (ARX) :
- FY22 PRODUCT SALES GUIDANCE OF $30M-33M
- TOTAL REVENUE FOR FY21 WAS $22.3M
- NORMALISED LOSS BEFORE INCOME TAX FOR FY21 WAS $7.4M
- PRODUCT GROSS MARGINS EXPECTED TO IMPROVE IN H2 FY22
May 25 (Reuters) - Aroa Biosurgery Ltd (ARX) : FY22 PRODUCT...
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ARX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
63.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $216.8M | |||
| Open | High | Low | Value | Volume |
| 63.0¢ | 63.0¢ | 62.0¢ | $25.26K | 40.21K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 657 | 62.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 63.0¢ | 4760 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| ARX (ASX) Chart |